IKBKB and colitis: Although, ginsenoside Rb1 and its metabolites have been confirmed playing an beneficial role in inflammatory responses in TNBS-induced colitis by inhibiting IRAK-1 activation, which contributes to activate IKKβ, linking with NF-κB and MAPK pathways [12].